Café

© 2026 Longbridge｜Terms of Service Privacy Policy

GIANT BIOGENE

02367

26.3802.57% ( +0.660 )

Delay Trading: Sep 4, 14:59:04

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Hong Kong Market Rotations: Mixed Mid-Year Signals Across Sectors
Global Report·2 days ago, 10:13 AM
- Hong Kong stocks' interim reporting season for 2026 reveals divergent profitability across infrastructure, consumption, and medical sectors. - CK Infrastructure Holdings reported a net profit surge exceeding 380 % driven by asset sales, while Nongfu Spring achieved over 16 % profit growth despite withholding interim dividends. - Pharmaron transitioned to a net loss due to strategic acquisitions, and China Overseas Property saw a 9 % profit decline amid industry pressure.
01038-0.08%09633+1.83%
Weekly Recap | GIANT BIOGENE -1.03%, a choppy week
Weekly Review·Aug 29 at 04:33 AM
02367+2.72%
The 2026 Hong Kong Mosaic: A Market Caught Between Legacy Debt and Biotech Ambitions
Global Report·Aug 25 at 10:12 AM
- In 2026, the Hong Kong stock market reflects China 's broader economic transition away from traditional debt - driven models toward high - value innovation. - Traditional pillars like Country Garden are repairing balance sheets through restructuring, while innovative firms such as Henlius report strong 2026 first - half revenues of RMB 3.588 billion with global expansions. - Diverse sectors including tech, green energy, and consumer goods demonstrate survival strategies across cycles, while awaiting answers on deleveraging and overseas resistance.
01801-0.19%06693-1.55%
Top 10 HK Stock Losers (8.21)
Top Gainers&Losers·Aug 22 at 08:31 AM
09899+2.84%01780-0.30%
Weekly Recap | GIANT BIOGENE -7.39%, interim results miss estimates
Weekly Review·Aug 22 at 04:02 AM
02367+2.72%
HSBC Research Cuts GIANT BIOGENE TP to HKD28.1, Maintains Hold Rating
AASTOCKS News·Aug 21 at 08:11 AM
02367+2.72%
Giant Biogene climbs 4% in HK as sector rally offsets mixed earnings
HK Stock Market Update·Aug 20 at 01:44 AM
02367+2.72%
Giant Biogene climbs 3% on medical-aesthetics pipeline hopes despite H1 profit drop
HK Stock Market Update·Aug 20 at 01:43 AM
02367+2.72%
Giant Biogene Holding (SEHK:2367) Stock Confronts Margin Squeeze After Profit Pullback
Simplywall·Aug 19 at 03:43 PM
02367+2.72%
GIANT BIOGENE Slumps Over 5% as G Sachs Cuts TP to HKD33 on Weaker-than-Expected Interim Operating Profit, Maintains Buy Rating
AASTOCKS News·Aug 19 at 03:56 AM
02367+2.72%
Citi Raises GIANT BIOGENE TP to HKD38.4; Recovery Visibility High
AASTOCKS News·Aug 19 at 02:31 AM
02367+2.72%
Giant Biogene tumbles 7% in Hong Kong trading as consumer stocks slump
HK Stock Market Update·Aug 19 at 01:42 AM
02367+2.72%
Hong Kong Micro-Fundamentals Diverge as AI Hardware Booms and Biotech Faces Earnings Reality Check
Global Report·Aug 18 at 10:12 AM
02577-2.04%03887+1.81%
GIANT BIOGENE Interim Net Profit RMB940 million, Down 20.5% YoY
AASTOCKS News·Aug 18 at 10:11 AM
02367+2.72%